Assembly Biosciences (ASMB) Enterprise Value (2010 - 2026)

Assembly Biosciences' Enterprise Value history runs 17 years deep, the most recent figure standing at -$226.6 million for Q1 2026.

• In Q1 2026, Enterprise Value fell 148.94% year-over-year to -$226.6 million; the TTM figure through Mar 2026 stood at -$226.6 million (down 148.94% YoY), while the FY2025 annual figure was -$248.1 million, down 121.37% from the prior year.
• Enterprise Value for Q1 2026 stood at -$226.6 million, up from -$248.1 million in the prior quarter.
• The five-year high for Enterprise Value was -$46.2 million in Q3 2023, with the low at -$248.1 million in Q4 2025.
• The 5-year median for Enterprise Value is -$109.2 million (2024), against an average of -$120.7 million.
• The sharpest annual moves came in 2023 and 2026: Enterprise Value jumped 57.47% in 2023, then tumbled 148.94% in 2026.
• Assembly Biosciences' Enterprise Value stood at -$91.6 million in 2022, then plunged by 42.18% to -$130.2 million in 2023, then climbed by 13.95% to -$112.1 million in 2024, then tumbled by 121.37% to -$248.1 million in 2025, then climbed by 8.67% to -$226.6 million in 2026.
• Business Quant data shows ASMB's Enterprise Value at -$226.6 million in Q1 2026, -$248.1 million in Q4 2025, and -$232.6 million in Q3 2025.